The Wolverine Blend is a synergistic peptide matrix engineered for advanced research into concurrent vascular synthesis and cellular motility. This dual-action formulation combines two prominent tissue-remodeling analogs in a standard ratio:

• BPC-157 (Gastric-Derived Angiogenic Pentadecapeptide): Researched for its cytoprotective properties, upregulating Vascular Endothelial Growth Factor (VEGF) pathways, and formatting collateral collagen matrices.
• TB-500 (Thymosin Beta-4 Fragment Analogue): Included to track G-actin regulation, actin polymerization, and cellular migration toward areas of tissue disruption. By pairing these compounds in a single vial, the matrix provides laboratory models with a streamlined platform to study overlapping tissue regeneration mechanisms.

• Form: Lyophilized (Freeze-Dried) multi-compound formulation
• Unit Mass: Total blended mass per vial (Batch dependent)
• Purity Level: Each component verified ≥98% pure via independent mass spectrometry prior to blending (See batch paperwork)
• Storage Matrix: Store long-term at -20°C to preserve structural integrity.